Abstract | OBJECTIVE: To investigate the differences in bone turnover between diabetic patients and controls. DESIGN: A systematic review and meta-analysis. METHODS: A literature search was conducted using the databases Medline at PubMed and EMBASE. The free text search terms ' diabetes mellitus' and 'bone turnover', 'sclerostin', 'RANKL', ' osteoprotegerin', ' tartrate-resistant acid' and 'TRAP' were used. Studies were eligible if they investigated bone turnover markers in patients with diabetes compared with controls. Data were extracted by two reviewers. RESULTS: A total of 2881 papers were identified of which 66 studies were included. Serum levels of the bone resorption marker C-terminal cross-linked telopeptide (-0.10 ng/mL (-0.12, -0.08)) and the bone formation markers osteocalcin (-2.51 ng/mL (-3.01, -2.01)) and procollagen type 1 amino terminal propeptide (-10.80 ng/mL (-12.83, -8.77)) were all lower in patients with diabetes compared with controls. Furthermore, s- tartrate-resistant acid phosphatase was decreased in patients with type 2 diabetes (-0.31 U/L (-0.56, -0.05)) compared with controls. S-sclerostin was significantly higher in patients with type 2 diabetes (14.92 pmol/L (3.12, 26.72)) and patients with type 1 diabetes (3.24 pmol/L (1.52, 4.96)) compared with controls. Also, s- osteoprotegerin was increased among patients with diabetes compared with controls (2.67 pmol/L (0.21, 5.14)). CONCLUSIONS: Markers of both bone formation and bone resorption are decreased in patients with diabetes. This suggests that diabetes mellitus is a state of low bone turnover, which in turn may lead to more fragile bone. Altered levels of sclerostin and osteoprotegerin may be responsible for this.
|
Authors | Katrine Hygum, Jakob Starup-Linde, Torben Harsløf, Peter Vestergaard, Bente L Langdahl |
Journal | European journal of endocrinology
(Eur J Endocrinol)
Vol. 176
Issue 3
Pg. R137-R157
(Mar 2017)
ISSN: 1479-683X [Electronic] England |
PMID | 28049653
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Copyright | © 2017 European Society of Endocrinology. |
Chemical References |
- Adaptor Proteins, Signal Transducing
- Biomarkers
- Bone Morphogenetic Proteins
- C-terminal cross-linking telopeptide of type II collagen, human
- Collagen Type II
- Genetic Markers
- Osteoprotegerin
- Peptide Fragments
- Procollagen
- SOST protein, human
- procollagen Type I N-terminal peptide
- Osteocalcin
- Tartrate-Resistant Acid Phosphatase
|
Topics |
- Adaptor Proteins, Signal Transducing
- Biomarkers
(blood)
- Bone Morphogenetic Proteins
(blood)
- Bone Remodeling
(physiology)
- Case-Control Studies
- Collagen Type II
(blood)
- Diabetes Mellitus, Type 1
(blood, physiopathology)
- Diabetes Mellitus, Type 2
(blood, physiopathology)
- Genetic Markers
- Humans
- Osteocalcin
(blood)
- Osteoprotegerin
(blood)
- Peptide Fragments
(blood)
- Procollagen
(blood)
- Tartrate-Resistant Acid Phosphatase
(blood)
|